Personalised’ treatment opens frontiers in cancer care

Cancer treatment is slowly moving away from the one-size-fits-all regime dominated by platinum-based chemotherapy in many countries like the US and Switzerland. Instead, it is fast embracing “personalised healthcare” based on the high-resolution molecular information of patients. In this , patients with the same type of cancer are given specific drugs or a combination therapy after identifying the genetic mutation responsible for his tumour through comprehensive genomic profiling(CGP).

To know more click here